Evidence map›Paper›PMID 37322510›Full record

ArticleBMC public health2023

Feasibility and acceptability of peer-delivered HIV self-testing and PrEP for young women in Kampala, Uganda.

Rita Nakalega, Nelson Mukiza, Robert Menge, Samuel Kizito, Juliet Allen Babirye, Cynthia Ndikuno Kuteesa, Denis Mawanda, Emmie Mulumba, Josephine Nabukeera, Joseph Ggita and 15 more

Abstract read
In one paragraph

Article in BMC public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Rita NakalegaMakerere University-Johns Hopkins University (MU-JHU) Research Collaboration, Kampala, Uganda. rnakalega@mujhu.org.
Nelson MukizaRineCynth Advisory, Kampala, Uganda.
Robert MengeUniversity of Stavanger, Stavanger, Norway.
Samuel KizitoBrown School at Washington University, Saint Louis, MO, USA.
Juliet Allen BabiryeMakerere University-Johns Hopkins University (MU-JHU) Research Collaboration, Kampala, Uganda.
Cynthia Ndikuno KuteesaRineCynth Advisory, Kampala, Uganda.
Denis MawandaRineCynth Advisory, Kampala, Uganda.
Emmie MulumbaMakerere University-Johns Hopkins University (MU-JHU) Research Collaboration, Kampala, Uganda.
Josephine NabukeeraMakerere University-Johns Hopkins University (MU-JHU) Research Collaboration, Kampala, Uganda.
Joseph GgitaMakerere University-Johns Hopkins University (MU-JHU) Research Collaboration, Kampala, Uganda.
Lydia NakanjakoRineCynth Advisory, Kampala, Uganda.
Carolyne AkelloMakerere University-Johns Hopkins University (MU-JHU) Research Collaboration, Kampala, Uganda.
Brenda Gati MirembeMakerere University-Johns Hopkins University (MU-JHU) Research Collaboration, Kampala, Uganda.
Zubair LukyamuziMakerere University-Johns Hopkins University (MU-JHU) Research Collaboration, Kampala, Uganda.
Catherine NakayeMakerere University-Johns Hopkins University (MU-JHU) Research Collaboration, Kampala, Uganda.
Hajira KataikeMakerere University-Johns Hopkins University (MU-JHU) Research Collaboration, Kampala, Uganda.
Joel MaenaMakerere University-Johns Hopkins University (MU-JHU) Research Collaboration, Kampala, Uganda.
Juliane EtimaMakerere University-Johns Hopkins University (MU-JHU) Research Collaboration, Kampala, Uganda.
Hadijah Kalule NabunyaMakerere University-Johns Hopkins University (MU-JHU) Research Collaboration, Kampala, Uganda.
Florence BiiraMakerere University-Johns Hopkins University (MU-JHU) Research Collaboration, Kampala, Uganda.
Christine NagawaMakerere University-Johns Hopkins University (MU-JHU) Research Collaboration, Kampala, Uganda.
Renee HeffronUniversity of Washington, Seattle, WA, USA.
Connie CelumUniversity of Washington, Seattle, WA, USA.
Monica GandhiUniversity of California San Francisco, San Francisco, California, USA.
Andrew MujugiraUniversity of Washington, Seattle, WA, USA.

Funding

UJMT – ORWH – Gazzetta, Issa-BoubeD43TW009340 · FIC · UNIV OF NORTH CAROLINA CHAPEL HILL · PI William Checkley, Benjamin H. Chi · 2017 to 2026
$14.8M
Randomized Trial to Optimize Virologic Suppression Rates Using a Point-of-Care Urine Monitoring Assay (ROVING-PUMA)R01AI143340 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Monica Gandhi · 2018 to 2026
$5.6M
“Hair Lengthening”: Using Hair Levels to Interpret Long-Acting PrEP Studies.R37AI098472 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Monica Gandhi · 2023 to 2026
$3.2M
Strengthening Child Health Research Capacity in Resource Constrained Settings: Researcher Resilience Training (RRT)R25MH118935 · NIMH · WASHINGTON UNIVERSITY · PI SEAN JOE, Mary McKernan McKay · 2018 to 2026
$1.5M
Transgender Men and HIV in Uganda: PrEP Uptake and PersistenceR34MH121084 · NIMH · INFECTIOUS DISEASES INSTITUTE · PI MUJUGIRA, ANDREW · 2019 to 2021
$584k
A Novel Video-Based Intervention to Enhance Optimal Uptake of Malaria Preventive Therapy: A Pilot Study of a Health Educational Approach to Malaria Prevention during PregnancyR03HD106185 · NICHD · MU-JHU CARE · PI NAKALEGA, RITA · 2022 to 2023
$108k
NIAID NIH HHS R01 AI143340NIAID NIH HHS R37 AI098472NICHD NIH HHS R03 HD106185NIH HHS D43TW009340NIH HHS MH121084NIMH NIH HHS R25 MH118935NIMH NIH HHS R34 MH121084
6 · The paper itself

Abstract

backgroundAdolescent girls and young women (AGYW) account for 29% of new HIV infections in Uganda despite representing just 10% of the population. Peer support improves AGYW linkage to HIV care and medication adherence. We evaluated the feasibility and acceptability of peer delivered HIV self-tests (HIVST) and oral pre-exposure prophylaxis (PrEP) to young women in Uganda.

methodsBetween March and September 2021, we conducted a pilot study of 30 randomly selected young women, aged 18-24 years, who had received oral PrEP for at least three months, but had suboptimal adherence as measured by urine tenofovir testing (< 1500 ng/ml). Participants were offered daily oral PrEP and attended clinic visits three and six months after enrollment. Between clinic visits, participants were visited monthly by trained peers who delivered HIVST and PrEP. Feasibility and acceptability of peer-delivered PrEP and HIVST (intervention) were measured by comparing actual versus planned intervention delivery and product use. We conducted two focus groups with young women, and five in-depth interviews with peers and health workers to explore their experiences with intervention delivery. Qualitative data were analyzed using thematic analysis.

resultsAt baseline, all 30 enrolled young women (median age 20 years) accepted peer-delivered PrEP and HIVST. Peer delivery visit completion was 97% (29/30) and 93% (28/30) at three and six months, respectively. The proportion of participants with detectable tenofovir in urine was 93% (27/29) and 57% (16/28) at months three and six, respectively. Four broad themes emerged from the qualitative data: (1) Positive experiences of peer delivered HIVST and PrEP; (2) The motivating effect of peer support; (3) Perceptions of female controlled HIVST and PrEP; and (4) Multi-level barriers to HIVST and PrEP use. Overall, peer delivery motivated young women to use HIVST and PrEP and encouraged persistence on PrEP by providing non-judgmental client-friendly services and adherence support.

conclusionPeer delivery of HIVST and oral PrEP was feasible and acceptable to this sample of young women with suboptimal PrEP adherence in Uganda. Future larger controlled studies should evaluate its effectiveness among African AGWY.

Indexed as

Anti-HIV AgentsHIV InfectionsPre-Exposure ProphylaxisAdolescentAdultFeasibility StudiesFemaleHumansPilot ProjectsSelf-TestingTenofovirUgandaYoung AdultAnti-HIV AgentsTenofovirHIVOral PrEPPeer deliverySelf-testingYoung women

Identifiers

PMID37322510
PMCPMC10273744

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.